Introduction
============

By 2010, elevated blood pressure (BP) became the leading risk factor of disease burden on a global basis.^[@b1]^ The insidious nature of hypertension is substantiated by its increasing prevalence, its mostly asymptomatic nature, and its poor drug control. Indeed, globally more than 1 billion people suffer from hypertension, but only 40% to 50% of those on therapy reach the targets of treatment.^[@b2]--[@b3]^ This is most unfortunate since even a small lowering of elevated BP results in significant reduction of cardiovascular events.

Family, twin, and adoption studies have suggested that heritability accounts for 30% to 50% of interindividual variation of BP.^[@b4]--[@b6]^ Recent extensive genome‐wide association studies have revealed \>40 genetic loci associated with essential hypertension,^[@b4]--[@b6]^ but even combined they account for only 2% of variability of BP, and no variant is of proven clinical value in guiding antihypertensive drug treatment. Until 2009, pharmacogenomic studies of hypertension suffered from narrow selection of candidate genes, small sample sizes, and weaknesses in study design.^[@b7]^ In subsequent studies, suggestive but inconsistent associations were reported when panels of gene variants selected by data from the hypertension genome‐wide association studies were screened in the Genetics of Drug Responsiveness in Essential Hypertension (GENRES)^[@b8]^ and Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)^[@b9]^ cohorts. Recently, the first applications of genome‐wide association studies principles in pharmacogenomics of hypertension have taken place,^[@b10]--[@b12]^ but there is still a need for controlled randomized studies with adequate replication of data using results from other laboratories.

The GENRES study is a randomized, double‐blind, cross‐over, placebo‐controlled study of 228 hypertensive men who received 4 different classes of antihypertensive drugs (a diuretic, β‐blocker, calcium‐channel blocker, and angiotensin receptor antagonist), each as a monotherapy, in a rotational manner.^[@b13]^ Both office (OBP) and 24‐hour ambulatory (ABP) blood pressure responses were measured. We here report genome‐wide analysis of association of 0.7M single‐nucleotide polymorphisms (SNPs) to the different antihypertensive drug responses, and also provide results from attempts to replicate findings using meta‐analysis data from the PEAR,^[@b14]^ Genetic Epidemiology of Responses to Antihypertensives (GERA) I,^[@b15]^ GERA II,^[@b10]^ and Study of the Pharmacogenomics in Italian hypertensive patients treated with the Angiotensin receptor blocker losartan (SOPHIA)^[@b16]^ studies.

Methods
=======

Study Participants
------------------

The design of the GENRES Study with initial clinical and biochemical data has been described previously.^[@b13],[@b17]^ In brief, a total of 313 moderately hypertensive Finnish men (aged 35 to 60 years) were initially screened.^[@b13]^ Inclusion criteria were diastolic BP ≥95 mm Hg in repeated measurements or use of antihypertensive medication. Exclusion criteria were use of 3 or more antihypertensive drugs, secondary hypertension, or significant comorbidity. There was no evident heart, cerebrovascular, liver, pulmonary, or kidney disease, and no patient had drug‐treated diabetes. No participant had signs of abuse of alcohol or drugs. Each study participant received losartan 50 mg, bisoprolol 5 mg, hydrochlorothiazide 25 mg, and amlodipine 5 mg daily, each as a monotherapy in randomized order for 4 weeks. The study started with a 4‐week run‐in placebo period, and all 4 drug treatment periods were separated by 4‐week placebo periods. Twenty‐four‐hour ABP readings were recorded at the end of each treatment period with a device equipped with a QRS complex detector and a position sensor (Diasys Integra; Novacor, Rueil‐Malmaison, France); in addition, OBP measurements were carried out with repeated measurements after a 30‐minute rest in the sitting position using a semiautomatic oscillometric device. In this study, ABP responses to the 4 monotherapies were analyzed. The 228 subjects who were successfully genotyped and had ABP response data from at least 1 drug treatment period are included in this study. Of these subjects, 212, 204, and 177 had ABP response data from 2, 3, and 4 drug treatments, respectively.

The clinical part of the GENRES study was conducted in accordance with the Declaration of Helsinki and Guidelines for Good Clinical Practice (1996) at Helsinki University Central Hospital between years 1999 and 2004. The study was approved by the Ethical Committee of Helsinki University Central Hospital and the National Agency for Medicines of Finland. All subjects gave signed informed consent before any study‐related activities.

PEAR is a study of mild‐‐to‐‐moderate hypertensives, with diastolic OBP \>90 mm Hg (and ≤110 mm Hg) and diastolic home BP \>85 mm Hg. The details of the study design have been described previously.^[@b14]^ In brief, the patients had no history of cardiovascular disease or diabetes and were between the ages of 17 and 65 years. After an average washout period of 28 days, they had baseline data collected, which included measurement of home, office, and 24‐hour ABP, along with collection of biological samples. They were then randomized to atenolol 50 mg daily or hydrochlorothiazide 12.5 mg daily. Following 3 weeks on this dose, those with BP \>120/70 mm Hg had the dose doubled, followed by an additional 6 weeks of treatment, after which BP data were collected along with biological samples. The 24‐hour ABP data were used for this analysis. Only subjects of European ancestry were included in the present study.

For each of the GERA I and II studies, 300 whites (in Rochester, MN) and 300 African Americans (in Atlanta, GA) were enrolled.^[@b18]--[@b19]^ The participants had uncomplicated primary hypertension, stage 1 to 2, and were 30 to 59.9 years of age. They were instructed to discontinue previous antihypertensive medications for ≥4 weeks. Once stable elevation of the BP was achieved (diastolic OBP ≥90 mm Hg), the study drug was administered orally: hydrochlorothiazide 25 mg daily for 4 weeks or candesartan 16 mg daily for 2 weeks followed by 32 mg daily for an 4 additional weeks. At the end of the drug‐free and drug‐treatment periods, 3 readings of BP were made by a trained assistant after the participant had been seated quietly for at least 5 minutes. The difference between averages of the second and third diastolic BP readings taken before and at the end of drug treatment was calculated as the BP response. Only subjects of European ancestry were included in the present study.

The SOPHIA Study is a study of mild‐to‐moderate, asymptomatic, never‐treated hypertensive patients (85% of participants), or patients out of treatment for at least 6 months (15% of participants).^[@b16]^ At the screening visit (week ‐8), participants ranging 18 to 59 years of age had to display systolic OBP from 140 to 179 mm Hg and diastolic OBP from 90 to 109 mm Hg. At each visit, OBP was measured 3 times, using a certified electronic device, with the subject in the sitting position after 5 minutes\' rest. During a run‐in period of 8 weeks, the participants followed a diet program that provided 100 to 140 mEq of sodium and 50 to 70 mEq of potassium daily to minimize the lifestyle differences. At the end of this period, 50 mg/day of losartan as open‐label was prescribed for 4 weeks.

Genotyping Methods
------------------

The DNA samples of 228 GENRES study subjects were successfully genotyped (success rates \>99%) at the Institute for Molecular Medicine Technology Centre, University of Helsinki using the Illumina HumanOmniExpress‐12 BeadChip (Illumina, Inc, San Diego, CA). The genotypes (NCBI build 37, hg19) were called and quality controlled using GenomeStudio v. 2011.1 software (Illumina, Inc) and in‐house‐developed database tools. Further quality steps, including identity‐by‐state clustering and gender check, were performed using Plink software and PLINK v1.07 toolset.^[@b20]^ Of the total of 709 357 genotyped autosomal SNPs, 707 658 passed these quality‐control steps. After this, SNPs with Hardy‐Weinberg equilibrium *P* value \<1×10^−5^ (393 SNPs) and minor allele frequency \<0.01 (75 421 SNPs) were excluded, which resulted in 631 844 autosomal SNPs that were used for analysis.

DNA samples from PEAR were genotyped using Illumina Human Omni1‐Quad BeadChip (Illumina) as previously described.^[@b11]^ DNA samples from GERA I and II study participants were genotyped using the Affymetrix GeneChip Human Mapping 6.0 Array Sets.^[@b10]--[@b11]^ SOPHIA samples were genotyped using the Illumina Human1M‐Duo array (Illumina) and imputed using MACH software and the HapMap CEU haplotypes (release 22) as reference.

Statistical Analyses
--------------------

As the first step of the present study, systolic (ASBP) and diastolic (ADBP) 24‐hour ambulatory blood pressure responses to each of the 4 monotherapies were analyzed separately in the GENRES Study (discovery sample). The BP response was calculated as BP after 4 weeks\' drug treatment minus mean BP after placebo periods. The mean BP level of all (up to 4) placebo periods, as opposed to the 1 preceding placebo period, was used as the baseline level to reduce BP variation. The approach was supported by several analyses. First, the BP responses to study drugs showed clearly lower variation when mean of all placebo periods was used as the baseline level (Table S1). Second, compared with the other drugs, amlodipine seemed to have a small carry‐over effect (≈−1.5/−0.5 mm Hg) based on placebo BP levels 4 weeks after amlodipine treatment (Table S2). The randomized cross‐over design and the use of all placebo periods as the baseline level eliminates any systematic effect of this finding on the results. In addition, the effect was probably even smaller after an additional 4 weeks when BP response to the next study drug was assessed. Third, the higher variation of placebo BP levels when only 1 placebo period was used can be seen in Table S2 as higher SDs. Finally, the preceding study treatment and the order of the drug treatment periods had no effect on BP response to any of the study drug when they were tested with regression analysis (GLM Univariate procedure of IBM SPSS Statistics program, version 19).

For the genome‐wide analyses, ASBP and ADBP response residuals were generated using IBM SPSS Statistics program and stepwise linear regression. The following covariates were tested with *P*\<0.10 as an inclusion condition: corresponding placebo ABP (mean of all periods), age, earlier use of antihypertensive medication (coded as 0/1), current smoking (coded as 0/1), body mass index, daily urinary sodium excretion after the first placebo period, and serum creatinine level after the first placebo period. For non‐normally distributed covariates, normalized values were used. The covariates selected for calculation of BP response residuals (in mm Hg) for each study drug are listed in Table S3.

The genome‐wide association analysis was done using covariate‐adjusted BP responses and linear regression under an additive genetic model with program PLINK.^[@b20]^ For each of the 4 study drugs, we report here the 20 genetic loci with the lowest *P* values based on either ASBP or ADBP responses. *P* values \<5×10^−8^ were considered as significant at the genome‐wide level.

In the second step, replication analyses of the 20 best loci associated with losartan, bisoprolol, and hydrochlorothiazide responses were carried out using the data from PEAR, GERA I, GERA II, and SOPHIA studies. In each case, the analyses were confined to study participants of European ancestry only, and age, gender, baseline BP, and principal components to account for ancestry were used as covariates. Accordingly, we replicated losartan/GENRES data using losartan/SOPHIA and candesartan/GERA II data, bisoprolol/GENRES data using atenolol/PEAR data, and hydrochlorothiazide/GENRES data using both hydrochlorothiazide/PEAR and hydrochlorothiazide/GERA I data. Successful replication was defined as *P* values below the Bonferroni‐corrected level of 2.5×10^−4^ (number of individual tests: 99 SNPs in 5 replication study analyses×SBP+DBP responses=198) and the same direction of effect. Suggestive replication was defined as *P* values \<0.05 and the same direction of effect.

As the third step, meta‐analyses of the top 20 GENRES 24‐hour ambulatory blood pressure response SNPs in all available studies were performed using inverse‐variance model with fixed effects in METAL.^[@b21]^ We defined significant results as *P* values \<5×10^−8^. In addition, *P* values \<1×10^−5^ were considered to represent a suggestive association.

Results
=======

Study Subjects
--------------

Principal demographic and clinical data from the subjects of the GENRES Study are summarized in [Table 1](#tbl01){ref-type="table"}. The patients were all males, had a slightly elevated body mass index (none had body mass index \>32 kg/m^2^) and a moderate hypertension (mean OBP 152/100 mm Hg). No patient had drug‐treated diabetes or reduced kidney glomerular filtration rate. The BP reductions, as assessed by the ABP measurements, ranged from 4.8/1.7 mm Hg (hydrochlorothiazide) to 11.1/8.3 mm Hg (bisoprolol). Note that the study design used fixed doses of antihypertensive drugs, and no attempt was made to use equipotent doses.

###### 

Characteristics of the Subjects From the Genetics of Drug Responsiveness in Essential Hypertension (GENRES) Study

  -------------------------------------------------------- ------------------------
  Number of subjects                                       228
  Age, y                                                   50.6 (6.4)
  Body mass index, kg/m^2^                                 26.7 (2.7)
  ABP during placebo periods (systolic/diastolic, mm Hg)   135 (10)/93 (6)
  OBP during placebo periods (systolic/diastolic, mm Hg)   152 (13)/100 (7)
  ABP responses (systolic/diastolic, mm Hg)                
  Amlodipine (N=205)                                       −7.4 (7.2)/−4.9 (4.0)
  Bisoprolol (N=207)                                       −11.1 (6.2)/−8.3 (4.2)
  Hydrochlorothiazide (N=206)                              −4.8 (6.3)/−1.7 (4.1)
  Losartan (N=203)                                         −9.1 (6.7)/−6.1 (4.7)
  dU‐sodium, mmol/24 h                                     173 (70)
  Fasting serum glucose, mmol/L                            5.4 (0.6)
  Serum creatinine, mmol/L                                 86 (13)
  -------------------------------------------------------- ------------------------

Subjects with genome‐wide genetic data and ambulatory blood pressure recordings after at least 1 antihypertensive monotherapy are included. All subjects were males. Data are presented as mean (SD). ABP indicates 24‐h ambulatory blood pressure; dU, daily urinary excretion of; OBP, office blood pressure.

First Step: Genome‐Wide Association Analyses in GENRES
------------------------------------------------------

Manhattan plots providing genome‐wide associations of ≈630 000 SNPs with the antihypertensive responses to losartan, bisoprolol, amlodipine, and hydrochlorothiazide are illustrated in [Figure 1](#fig01){ref-type="fig"}. Three SNPs on chromosome 11 (rs2514036, rs948445, and rs2514037) provided evidence for association reaching genome‐wide significance for ASBP response to bisoprolol ([Figure 1](#fig01){ref-type="fig"}C and [Table 2](#tbl02){ref-type="table"}). These 3 SNPs map within the coding and regulatory regions of *ACY3*, coding for aminoacylase III. Altogether, 42 SNPs in 31 distinct regions were identified having at least 1 SNP associated with the treatment response at *P*≤1×10^−5^ ([Figure 1](#fig01){ref-type="fig"} and Tables [2](#tbl04){ref-type="table"} through [5](#tbl05){ref-type="table"}).

###### 

Single‐Nucleotide Polymorphisms Associated With 24‐H Ambulatory Blood Pressure Response to Bisoprolol in the Genetics of Drug Responsiveness in Essential Hypertension (GENRES) Study

  *P* Value Rank   SNP          Chr   Position (Build 37)   N     CA/NCA   CAF    SBP/DBP   BP Response   Other SNPs From the Same Locus With Low *P* Values (*r*^2^ Value With the Listed SNP)                                                                                                        
  ---------------- ------------ ----- --------------------- ----- -------- ------ --------- ------------- --------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                rs2514036    11    67 415 054            207   G/A      0.11   SBP       −5.4          ±0.9                                                                                    2.0E‐8                                                                                               rs948445 (*r*^2^=1.00), rs2514037 (*r*^2^=0.61)
                                                                           DBP    −3.1      ±0.6          1.4E‐6                                                                                                                                                                                       
  2                rs7268800    20    38 580 738            207   G/A      0.42   SBP       −2.1          ±0.6                                                                                    5.2E‐4                                                                                               rs6071822 (*r*^2^=0.52), rs211841 (*r*^2^=0.37), rs211840 (*r*^2^=0.37), rs7261610 (*r*^2^=0.61), rs11699371 (*r*^2^=0.58), rs16988591 (*r*^2^=0.68), rs11699530 (*r*^2^=1.00), rs958523 (*r*^2^=0.94), rs6124201 (*r*^2^=0.68)
                                                                           DBP    −1.9      ±0.4          2.1E‐6\*                                                                                                                                                                                     
  3                rs12967284   18    12 532 098            207   A/G      0.25   SBP       2.9           ±0.6                                                                                    7.8E‐6                                                                                               rs11663391 (*r*^2^=0.95)
                                                                           DBP    2.0       ±0.4          3.6E‐6\*                                                                                                                                                                                     
  4                rs4357510    1     192 612 394           207   A/C      0.06   SBP       −5.4          ±1.2                                                                                    1.4E‐5                                                                                               
                                                                           DBP    −3.8      ±0.8          4.2E‐6\*                                                                                                                                                                                     
  5                rs2506143    10    33 468 169            207   G/A      0.09   SBP       3.4           ±1.0                                                                                    4.7E‐4                                                                                               rs2506140 (*r*^2^=1.0), rs2506144 (*r*^2^=1.0)
                                                                           DBP    3.0       ±0.6          4.7E‐6\*                                                                                                                                                                                     
  6                rs2029870    6     164 888 366           204   A/G      0.14   SBP       −3.4          ±0.8                                                                                    4.3E‐5                                                                                               rs10945994 (*r*^2^=0.83)
                                                                           DBP    −2.6      ±0.5          5.0E‐6\*                                                                                                                                                                                     
  7                rs7984003    13    82 866 573            206   A/G      0.25   SBP       3.1           ±0.7                                                                                    5.4E‐6\*                                                                                             rs7984202 (*r*^2^=0.42), rs9531328 (*r*^2^=0.34), rs7993722 (*r*^2^=0.34)
                                                                           DBP    2.1       ±0.5          5.8E‐6                                                                                                                                                                                       
  8                rs11777699   8     6 714 699             206   G/A      0.50   SBP       −1.8          ±0.6                                                                                    1.4E‐3                                                                                               
                                                                           DBP    −1.7      ±0.4          5.9E‐6\*                                                                                                                                                                                     
  9                rs10519585   5     118 676 529           207   G/A      0.31   SBP       −2.5          ±0.6                                                                                    5.5E‐5                                                                                               
                                                                           DBP    −1.9      ±0.4          6.6E‐6\*                                                                                                                                                                                     
  10               rs6501061    16    8 092 171             207   G/A      0.09   SBP       4.7           ±1.0                                                                                    9.9E‐6\*                                                                                             
                                                                           DBP    2.3       ±0.7          1.5E‐3                                                                                                                                                                                       
  11               rs16918900   8     54 147 242            207   A/G      0.01   SBP       −8.4          ±2.4                                                                                    6.9E‐4                                                                                               
                                                                           DBP    −7.3      ±1.6          1.1E‐5\*                                                                                                                                                                                     
  12               rs2194860    4     109 948 511           207   A/G      0.19   SBP       3.2           ±0.7                                                                                    1.1E‐5\*                                                                                             
                                                                           DBP    1.9       ±0.5          1.7E‐4                                                                                                                                                                                       
  13               rs2765115    13    24 529 399            207   G/A      0.16   SBP       −3.7          ±0.8                                                                                    1.2E‐5\*                                                                                             rs6490847 (*r*^2^=0.89), rs2147990 (*r*^2^=0.49), rs2765089 (*r*^2^=0.33),
                                                                           DBP    −2.3      ±0.6          8.1E‐5                                                                                  rs2492084 (*r*^2^=0.47), rs9510968 (*r*^2^=0.32), rs2765114 (*r*^2^=0.59), rs2765119 (*r*^2^=0.37)   
  14               rs17642669   5     140 628 277           207   G/A      0.06   SBP       −3.9          ±1.3                                                                                    2.1E‐3                                                                                               rs17629216 (*r*^2^=1.0)
                                                                           DBP    −3.7      ±0.8          1.4E‐5\*                                                                                                                                                                                     
  15               rs7895038    10    2 432 266             207   G/A      0.41   SBP       −2.7          ±0.6                                                                                    1.5E‐5\*                                                                                             rs826474 (*r*^2^=0.47), rs826489 (*r*^2^=0.52)
                                                                           DBP    −1.4      ±0.4          1.1E‐3                                                                                                                                                                                       
  16               rs150210     21    19 362 312            207   G/A      0.28   SBP       −2.7          ±0.6                                                                                    1.8E‐5\*                                                                                             
                                                                           DBP    −1.5      ±0.4          7.2E‐4                                                                                                                                                                                       
  17               rs10910862   1     181 045 421           207   A/G      0.06   SBP       −5.1          ±1.3                                                                                    9.0E‐5                                                                                               
                                                                           DBP    −3.7      ±0.8          1.9E‐5\*                                                                                                                                                                                     
  18               rs2148117    10    27 213 946            207   G/A      0.02   SBP       −9.1          ±2.1                                                                                    1.9E‐5\*                                                                                             
                                                                           DBP    −5.8      ±1.4          5.6E‐5                                                                                                                                                                                       
  19               rs1150433    3     163 653 210           207   A/G      0.13   SBP       −3.6          ±0.9                                                                                    8.9E‐5                                                                                               
                                                                           DBP    −2.6      ±0.6          2.0E‐5\*                                                                                                                                                                                     
  20               rs969981     17    63 818 989            206   A/G      0.16   SBP       −3.3          ±0.7                                                                                    2.0E‐5\*                                                                                             
                                                                           DBP    −1.6      ±0.5          2.2E‐3                                                                                                                                                                                       

Twenty loci with the lowest *P* values based on either systolic or diastolic response are listed. BP indicates blood pressure; CA, coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NCA, noncoded allele; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

Lowest *P* value of each locus.

###### 

Single‐Nucleotide Polymorphisms Associated With 24‐H Ambulatory Blood Pressure Response to Losartan in the GENRES Study

  *P* Value Rank   SNP          Chr   Position (Build 37)   N     CA/NCA   CAF    SBP/DBP   BP Response   Other SNPs From the Same Locus With Low *P* Values (*r*^2^ Value With the Listed SNP)                                                                                
  ---------------- ------------ ----- --------------------- ----- -------- ------ --------- ------------- --------------------------------------------------------------------------------------- ---------------------------------------------------------------------------- ----------------------------------------------------------------------------
  1                rs1370555    15    97 049 985            203   G/A      0.40   SBP       −2.6          ±0.6                                                                                    4.4E‐5                                                                       
                                                                           DBP    −2.1      ±0.4          6.2E‐7\*                                                                                                                                                             
  2                rs7086428    10    130 778 452           203   A/G      0.37   SBP       3.3           ±0.6                                                                                    6.5E‐7\*                                                                     
                                                                           DBP    1.7       ±0.5          2.8E‐4                                                                                                                                                               
  3                rs4953045    2     44 268 800            203   G/A      0.25   SBP       −3.5          ±0.7                                                                                    1.1E‐6\*                                                                     rs17424646 (*r*^2^=0.28), rs4131366 (*r*^2^=0.32), rs17496908(*r*^2^=0.59)
                                                                           DBP    −2.2      ±0.5          1.0E‐5                                                                                                                                                               
  4                rs711513     7     109 368 769           200   G/A      0.36   SBP       −2.4          ±0.7                                                                                    5.6E‐4                                                                       rs2841921 (*r*^2^=0.95), rs10953645 (*r*^2^=0.39)
                                                                           DBP    −2.3      ±0.5          1.3E‐6\*                                                                                                                                                             
  5                rs12814605   12    63 438 145            203   A/G      0.15   SBP       −4.0          ±0.9                                                                                    1.4E‐5                                                                       rs1249935 (*r*^2^=0.33), rs12813083 (*r*^2^=0.30), rs699615 (*r*^2^=0.36)
                                                                           DBP    −3.0      ±0.6          2.3E‐6\*                                                                                rs699618 (*r*^2^=0.37), rs12823849 (*r*^2^=0.44), rs12815621 (*r*^2^=1.00)   
  6                rs2279989    9     1 041 524             203   A/G      0.10   SBP       −4.0          ±1.0                                                                                    1.6E‐4                                                                       
                                                                           DBP    −3.3      ±0.7          3.3E‐6\*                                                                                                                                                             
  7                rs7597606    2     41 836 313            202   A/G      0.40   SBP       2.9           ±0.6                                                                                    3.3E‐6\*                                                                     
                                                                           DBP    1.4       ±0.4          8.5E‐4                                                                                                                                                               
  8                rs1559557    2     57 332 673            203   G/A      0.32   SBP       3.3           ±0.7                                                                                    4.8E‐6\*                                                                     rs1424642 (*r*^2^=0.70), rs17048681 (*r*^2^=0.74)
                                                                           DBP    1.9       ±0.5          2.1E‐4                                                                                                                                                               
  9                rs1432232    2     137 799 664           203   A/C      0.18   SBP       3.8           ±0.8                                                                                    5.8E‐6\*                                                                     rs1347033 (*r*^2^=0.79)
                                                                           DBP    2.2       ±0.6          1.2E‐4                                                                                                                                                               
  10               rs1993802    3     110 595 402           203   G/A      0.17   SBP       −3.9          ±0.9                                                                                    1.1E‐5\*                                                                     rs7637068 (*r*^2^=0.94), rs1462795 (*r*^2^=0.94), rs4450855 (*r*^2^=0.94)
                                                                           DBP    −2.6      ±0.6          1.2E‐5                                                                                  rs1477841 (*r*^2^=0.94)                                                      
  11               rs12602832   17    42 396 896            202   A/G      0.14   SBP       −2.8          ±0.9                                                                                    1.6E‐3                                                                       
                                                                           DBP    −2.7      ±0.6          1.2E‐5\*                                                                                                                                                             
  12               rs2038912    10    20 207 349            203   A/G      0.49   SBP       2.0           ±0.6                                                                                    1.7E‐3                                                                       
                                                                           DBP    1.8       ±0.4          1.4E‐5\*                                                                                                                                                             
  13               rs4759885    12    131 736 813           203   G/A      0.46   SBP       −2.7          ±0.7                                                                                    7.3E‐5                                                                       rs4387437 (*r*^2^=0.99), rs7488647 (*r*^2^=0.99), rs12578896 (*r*^2^=0.50)
                                                                           DBP    −2.0      ±0.5          1.5E‐5\*                                                                                                                                                             
  14               rs771574     3     101 620 682           203   G/A      0.24   SBP       −3.2          ±0.8                                                                                    3.9E‐5                                                                       
                                                                           DBP    −2.3      ±0.5          1.6E‐5\*                                                                                                                                                             
  15               rs10754459   1     245 785 508           203   G/A      0.30   SBP       −2.3          ±0.7                                                                                    1.3E‐3                                                                       
                                                                           DBP    −2.1      ±0.5          1.6E‐5\*                                                                                                                                                             
  16               rs1392874    4     101 466 820           203   A/C      0.45   SBP       −1.8          ±0.6                                                                                    4.3E‐3                                                                       rs11725047 (*r*^2^=0.09), rs4699824 (*r*^2^=0.17)
                                                                           DBP    −1.9      ±0.4          1.7E‐5\*                                                                                                                                                             
  17               rs1357365    17    34 436 532            203   A/G      0.22   SBP       2.6           ±0.7                                                                                    5.2E‐4                                                                       
                                                                           DBP    2.2       ±0.5          2.0E‐5\*                                                                                                                                                             
  18               rs3814995    19    36 342 212            202   A/G      0.35   SBP       −2.8          ±0.7                                                                                    2.0E‐5\*                                                                     
                                                                           DBP    −1.6      ±0.5          5.1E‐4                                                                                                                                                               
  19               rs11841583   13    31 495 179            203   A/G      0.10   SBP       −4.5          ±1.0                                                                                    2.6E‐5                                                                       
                                                                           DBP    −3.1      ±0.7          2.1E‐5\*                                                                                                                                                             
  20               rs17271855   19    5 524 721             203   A/G      0.18   SBP       −2.9          ±0.8                                                                                    5.0E‐4                                                                       
                                                                           DBP    −2.4      ±0.6          2.2E‐5\*                                                                                                                                                             

Twenty loci with the lowest *P* values based on either systolic or diastolic response are listed. BP indicates blood pressure; CA, coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NCA, noncoded allele; SBP, systolic blood pressure; SE, standard error of β; SNP, single‐nucleotide polymorphism.

\*Lowest *P* value of each locus.

###### 

Single‐Nucleotide Polymorphisms Associated With 24‐H Ambulatory Blood Pressure Response to Amlodipine in the GENRES Study

  *P* Value Rank   SNP          Chr   Position (Build 37)   N     CA/NCA   CAF    SBP/DBP   BP Response   Other SNPs From the Same Locus with Low *P* Values (*r*^2^ Value With the Listed SNP)                                                                    
  ---------------- ------------ ----- --------------------- ----- -------- ------ --------- ------------- --------------------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------
  1                rs7687961    4     187 122 009           205   C/A      0.21   SBP       3.6           ±0.7                                                                                    1.6E‐6\*                                                         rs3736456 (*r*^2^=0.36)
                                                                           DBP    1.6       ±0.4          1.5E‐4                                                                                                                                                   
  2                rs602618     10    112 843 085           205   C/A      0.24   SBP       3.6           ±0.7                                                                                    1.8E‐6\*                                                         rs4917589 (*r*^2^=0.36), rs10787287 (*r*^2^=0.55), rs10787292
                                                                           DBP    1.4       ±0.4          1.5E‐3                                                                                  (*r*^2^=0.66), rs521674 (*r*^2^=0.92), rs7923122 (*r*^2^=0.25)   
  3                rs17406681   2     212 403 387           205   A/G      0.20   SBP       3.4           ±0.7                                                                                    2.2E‐6\*                                                         
                                                                           DBP    1.5       ±0.4          2.4E‐4                                                                                                                                                   
  4                rs12921986   16    72 312 727            205   G/A      0.03   SBP       7.4           ±1.6                                                                                    6.8E‐6\*                                                         rs12933482 (*r*^2^=0.64), rs17604662 (*r*^2^=0.64)
                                                                           DBP    3.9       ±0.9          3.0E‐5                                                                                  rs17606532 (*r*^2^=0.78), rs34522712 (*r*^2^=0.78)               
  5                rs354706     2     143 886 216           205   G/A      0.40   SBP       2.7           ±0.6                                                                                    7.3E‐6\*                                                         
                                                                           DBP    1.2       ±0.3          3.9E‐4                                                                                                                                                   
  6                rs9814527    3     193 533 703           205   G/A      0.36   SBP       2.6           ±0.6                                                                                    7.4E‐6\*                                                         
                                                                           DBP    0.9       ±0.3          7.4E‐3                                                                                                                                                   
  7                rs10021692   4     188 080 985           205   G/A      0.17   SBP       3.5           ±0.8                                                                                    7.6E‐6\*                                                         rs882227 (*r*^2^=0.97)
                                                                           DBP    1.6       ±0.4          3.4E‐4                                                                                                                                                   
  8                rs352796     8     15 613 270            205   G/A      0.02   SBP       −8.9          ±2.3                                                                                    1.2E‐4                                                           
                                                                           DBP    −5.6      ±1.3          1.3E‐5\*                                                                                                                                                 
  9                rs11125895   2     62 069 358            205   G/A      0.19   SBP       2.5           ±0.8                                                                                    1.7E‐3                                                           
                                                                           DBP    1.9       ±0.4          1.3E‐5\*                                                                                                                                                 
  10               rs220457     17    30 102 635            205   G/A      0.25   SBP       2.9           ±0.6                                                                                    1.4E‐5\*                                                         
                                                                           DBP    1.4       ±0.4          1.8E‐4                                                                                                                                                   
  11               rs1947234    12    39 450 491            205   A/C      0.23   SBP       −3.0          ±0.7                                                                                    1.4E‐5\*                                                         
                                                                           DBP    −1.3      ±0.4          1.1E‐3                                                                                                                                                   
  12               rs6083017    20    23 119 766            205   A/G      0.51   SBP       −1.7          ±0.6                                                                                    4.6E‐3                                                           
                                                                           DBP    −1.4      ±0.3          1.5E‐5\*                                                                                                                                                 
  13               rs1504058    3     1 090 602             204   G/A      0.43   SBP       1.7           ±0.6                                                                                    4.2E‐3                                                           
                                                                           DBP    1.4       ±0.3          1.6E‐5\*                                                                                                                                                 
  14               rs526847     6     148 236 385           204   G/A      0.39   SBP       −2.7          ±0.6                                                                                    1.8E‐5\*                                                         rs498291 (*r*^2^=0.99)
                                                                           DBP    −1.0      ±0.4          3.8E‐3                                                                                                                                                   
  15               rs9577581    13    114 252 002           205   A/G      0.38   SBP       2.2           ±0.6                                                                                    8.0E‐4                                                           
                                                                           DBP    1.6       ±0.4          1.8E‐5\*                                                                                                                                                 
  16               rs17238902   10    67 649 378            205   A/G      0.13   SBP       −3.2          ±0.9                                                                                    3.0E‐4                                                           
                                                                           DBP    −2.1      ±0.5          1.9E‐5\*                                                                                                                                                 
  17               rs6706577    2     111 796 833           205   A/G      0.48   SBP       1.7           ±0.6                                                                                    4.1E‐3                                                           
                                                                           DBP    1.4       ±0.3          2.0E‐5\*                                                                                                                                                 
  18               rs2018975    10    317 501               205   A/G      0.40   SBP       2.5           ±0.6                                                                                    4.7E‐5                                                           rs2379078 (*r*^2^=0.81)
                                                                           DBP    1.5       ±0.3          2.4E‐5\*                                                                                                                                                 
  19               rs10821312   9     96 944 581            205   G/A      0.20   SBP       2.2           ±0.7                                                                                    2.4E‐3                                                           rs7038156 (*r*^2^=1.00)
                                                                           DBP    1.7       ±0.4          2.4E‐5\*                                                                                                                                                 
  20               rs9364385    6     168 415 372           205   A/G      0.50   SBP       2.4           ±0.6                                                                                    2.4E‐5\*                                                         rs1858675 (*r*^2^=1.00), rs3807061 (*r*^2^=0.96)
                                                                                  DBP       0.9           ±0.3                                                                                    4.2E‐3                                                           

Twenty loci with the lowest *P* values based on either systolic or diastolic response are listed. BP indicates blood pressure; CA, coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NCA, noncoded allele; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

\*Lowest *P* value of each locus.

###### 

Single‐Nucleotide Polymorphisms Associated With 24‐H Ambulatory Blood Pressure Response to Hydrochlorothiazide in the GENRES Study

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *P* Value Rank   SNP          Chr   Position (Build 37)   N     CA/NCA   CAF    SBP/DBP   BP Response   Other SNPs From the Same Locus With Low *P* values (*r*^2^ value With the Listed SNP)                                                       
  ---------------- ------------ ----- --------------------- ----- -------- ------ --------- ------------- --------------------------------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------------------
  1                rs4867623    5     170 071 480           206   A/G      0.20   SBP       −2.2          ±0.8                                                                                    5.6E‐3                                              rs9968589 (*r*^2^=0.64), rs9968699 (*r*^2^=0.78)

                                                                           DBP    −2.6      ±0.5          3.7E‐7\*                                                                                rs4868010 (*r*^2^=0.78), rs11747249 (*r*^2^=0.78)   

  1                rs4868010    5     170 092 760           206   A/C      0.16   SBP       −2.1          ±0.8                                                                                    1.1E‐2                                              (listed because of replication analysis in PEAR and

                                                                                  DBP       −2.4          ±0.5                                                                                    1.7E‐5                                              GERA)

  2                rs321320     6     45 702 779            205   G/A      0.14   SBP       −3.3          ±0.8                                                                                    3.7E‐5                                              rs321329 (*r*^2^=0.24)

                                                                           DBP    −2.5      ±0.5          2.3E‐6\*                                                                                                                                    

  2                rs321329     6     45 722 988            206   A/G      0.41   SBP       −2.2          ±0.6                                                                                    1.2E‐4                                              (Listed because of replication analysis in PEAR and

                                                                           DBP    −1.7      ±0.4          1.1E‐5                                                                                  GERA), rs3846898 (*r*^2^=0.57)                      

  3                rs11006074   10    59 941 452            206   G/A      0.13   SBP       3.3           ±0.9                                                                                    1.5E‐4                                              

                                                                           DBP    2.7       ±0.6          3.2E‐6\*                                                                                                                                    

  4                rs3117915    13    22 605 580            206   G/A      0.21   SBP       −2.0          ±0.7                                                                                    3.7E‐3                                              

                                                                           DBP    −2.1      ±0.5          8.6E‐6\*                                                                                                                                    

  5                rs7821547    8     13 541 779            206   A/G      0.22   SBP       2.6           ±0.7                                                                                    1.9E‐4                                              rs4831455 (*r*^2^=0.91)

                                                                           DBP    2.0       ±0.4          9.5E‐6\*                                                                                                                                    

  6                rs3825926    15    101 445 441           206   A/G      0.03   SBP       7.3           ±1.6                                                                                    1.0E‐5\*                                            rs4646660 (*r*^2^=0.62), rs4646672 (*r*^2^=0.87)

                                                                           DBP    3.8       ±1.1          6.6E‐4                                                                                  rs4246323 (*r*^2^=0.87), rs4246326 (*r*^2^=0.87)\   
                                                                                                                                                                                                  rs3803430 (*r*^2^=0.87), rs4646683 (*r*^2^=0.82)\   
                                                                                                                                                                                                  rs3803426 (*r*^2^=1.00), rs1802603 (*r*^2^=0.66)    

  7                rs2056531    17    47 283 058            206   A/G      0.11   SBP       3.1           ±0.9                                                                                    7.1E‐4                                              rs4438351 (*r*^2^=0.77), rs8077444 (*r*^2^=0.96), rs11868965

                                                                                  DBP       2.7           ±0.6                                                                                    1.1E‐5\*                                            (*r*^2^=0.96), rs2293215 (*r*^2^=1.00)

  8                rs6977301    7     42 497 247            206   A/G      0.08   SBP       4.4           ±1.0                                                                                    1.4E‐5\*                                            

                                                                           DBP    2.9       ±0.7          1.4E‐5                                                                                                                                      

  9                rs1553009    7     45 908 994            206   A/G      0.10   SBP       3.5           ±0.9                                                                                    1.7E‐4                                              

                                                                           DBP    2.7       ±0.6          1.4E‐5\*                                                                                                                                    

  10               rs2776906    6     37 431 757            206   A/G      0.36   SBP       2.6           ±0.6                                                                                    1.7E‐5\*                                            rs10692 (*r*^2^=1.00)

                                                                           DBP    1.3       ±0.4          9.6E‐4                                                                                                                                      

  11               rs964132     19    19 243 175            206   A/G      0.04   SBP       5.3           ±1.5                                                                                    6.5E‐4                                              

                                                                           DBP    4.4       ±1.0          1.7E‐5\*                                                                                                                                    

  12               rs158210     5     55 737 637            206   A/G      0.10   SBP       −4.1          ±0.9                                                                                    1.8E‐5\*                                            

                                                                           DBP    −2.5      ±0.6          8.8E‐5                                                                                                                                      

  13               rs1324210    9     114 791 150           206   A/G      0.25   SBP       2.8           ±0.6                                                                                    1.9E‐5\*                                            

                                                                           DBP    1.6       ±0.4          1.6E‐4                                                                                                                                      

  14               rs6546025    2     63 923 561            206   G/A      0.24   SBP       −1.8          ±0.6                                                                                    5.0E‐3                                              rs10201844 (*r*^2^=0.90), rs10187013 (*r*^2^=0.89)

                                                                           DBP    −1.8      ±0.4          2.0E‐5\*                                                                                rs6546038 (*r*^2^=0.84)                             

  15               rs11059985   12    129 347 891           206   A/G      0.29   SBP       2.8           ±0.6                                                                                    2.1E‐5\*                                            

                                                                           DBP    1.0       ±0.4          2.6E‐2                                                                                                                                      

  16               rs3799369    6     25 912 634            206   G/A      0.12   SBP       3.7           ±0.8                                                                                    2.1E‐5\*                                            

                                                                           DBP    1.7       ±0.6          4.0E‐3                                                                                                                                      

  17               rs17099050   14    100 255 923           206   C/A      0.03   SBP       7.2           ±1.7                                                                                    5.4E‐5                                              

                                                                           DBP    5.0       ±1.2          2.3E‐5\*                                                                                                                                    

  18               rs329668     11    133 795 219           205   A/G      0.13   SBP       3.5           ±0.8                                                                                    2.6E‐5\*                                            

                                                                           DBP    2.0       ±0.6          5.8E‐4                                                                                                                                      

  19               rs776472     7     114 352 862           206   G/A      0.43   SBP       −2.3          ±0.5                                                                                    2.8E‐5\*                                            

                                                                           DBP    −1.5      ±0.4          7.4E‐5                                                                                                                                      

  20               rs1922117    12    63 789 836            206   C/A      0.37   SBP       −2.1          ±0.6                                                                                    6.4E‐4                                              

                                                                           DBP    −1.7      ±0.4          3.1E‐5\*                                                                                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Twenty loci with the lowest *P* values based on either systolic or diastolic response are listed. BP indicates blood pressure; CA, coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NCA, noncoded allele; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

\*Lowest *P* value of each locus.

![Manhattan plots from the genome‐wide association analysis of the ambulatory blood pressure responses using an additive model. (A) Losartan, systolic; (B) losartan, diastolic; (C) bisoprolol, systolic; (D) bisoprolol, diastolic; (E) amlodipine, systolic; (F) amlodipine, diastolic; (G) hydrochlorothiazide, systolic; (H) hydrochlorothiazide, diastolic.](jah3-4-e001521-g1){#fig01}

The quantile‐quantile plots ([Figure 2](#fig02){ref-type="fig"}) show little evidence for genomic inflation and provide some support for the existence of significant associations with genomic loci influencing responsiveness to losartan and bisoprolol.

![Quantile‐quantile plots from the genome‐wide association analysis of the ambulatory blood pressure responses using an additive model. Single‐nucleotide polymorphisms with minor allele frequency \<0.01 are excluded. (A) Losartan, systolic; (B) losartan, diastolic; (C) bisoprolol, systolic; (D) bisoprolol, diastolic; (E) amlodipine, systolic; (F) amlodipine, diastolic; (G) hydrochlorothiazide, systolic; (H) hydrochlorothiazide, diastolic.](jah3-4-e001521-g2){#fig02}

The strongest associations for the 24‐hour ABP responses to the 4 different drug responses are listed in Tables [2](#tbl04){ref-type="table"} through [5](#tbl05){ref-type="table"}. In each case, 20 loci with the lowest *P* values for either ASBP or ADBP responses are indicated. For each locus listed, there was a remarkable congruence between the direction and relative extent of the systolic and diastolic BP lowering. None of the top 20 loci were shared between 2 or more drugs.

Second Step: Replication Analyses Using Individual Pharmacogenomics Studies
---------------------------------------------------------------------------

We carried out replication analyses of the top 20 significant associations with each antihypertensive response noted in the GENRES study, using data from 4 available studies: SOPHIA (losartan responses compared to those in GENRES), GERA II (candesartan responses, compared to losartan responses in GENRES), PEAR (atenolol responses, compared to bisoprolol responses in GENRES), and GERA I+PEAR (hydrochlorothiazide responses in all 3 studies). The participants of the replication studies are described in [Table 6](#tbl06){ref-type="table"}. Note that while the data from the GENRES and PEAR studies were based on ABP recordings, OBP measurements were used in SOPHIA, GERA I, and II. Composite results from these replication analyses are listed in Tables [7](#tbl08){ref-type="table"} through [9](#tbl09){ref-type="table"}. Two SNPs analyzed in GENRES were not available in the replication material GERA II (losartan/candesartan responses, [Table 7](#tbl07){ref-type="table"}) and 3 SNPs were not available in GERA I (hydrochlorothiazide responses, [Table 9](#tbl09){ref-type="table"}). Two flanking SNPs were included in the replication analysis of the GERA I data ([Table 9](#tbl09){ref-type="table"}). Unfortunately, data on responses to amlodipine could not be replicated in this collaborative study.

###### 

Description of Subjects in Replication Studies

                                               PEAR          PEAR         GERA I       GERA II       SOPHIA
  -------------------------------------------- ------------- ------------ ------------ ------------- -----------
  Treatment                                    Atenolol      HCTZ         HCTZ         Candesartan   Losartan
  Blood pressure measurement method            Ambulatory    Ambulatory   Office       Office        Office
  Number of subjects in replication analyses   193           193          196          198           372
  Women, N (%)                                 85 (44%)      80 (42%)     84 (43%)     98 (49%)      92 (25%)
  Age, y                                       50.0±9.4      50.6±9.1     48.6±7.3     49.1±6.8      45.7±7.4
  Body mass index, kg/m^2^                     30.1±5.4      30.2±4.9     31.3±5.6     29.9±3.9      26.9±2.9
  Baseline systolic blood pressure, mm Hg      138±10        139±11       143±13       147±13        149±7
  Baseline diastolic blood pressure, mm Hg     87±8          87±9         96±6         95±5          97±4
  Blood pressure responses                                                                           
  Atenolol, systolic response, mm Hg           −14.2 ±10.6                                           
  Atenolol, diastolic response, mm Hg          −10.6±7.9                                             
  HCTZ, systolic response, mm Hg                             −8.4±10.1    −10.9±13.0                 
  HCTZ, diastolic response, mm Hg                            −4.5±7.2     −6.3±8.8                   
  Candesartan, systolic response, mm Hg                                                −18.4±14.7    
  Candesartan, diastolic response, mm Hg                                               −13.4±10.2    
  Losartan, systolic response, mm Hg                                                                 −11.8±9.1
  Losartan, systolic response, mm Hg                                                                 −8.8±6.2

Only participants of European ancestry are included. Data are presented as mean±SD. HCTZ, hydrochlorothiazide.

###### 

Replication Analysis of the Best GENRES Losartan 24‐H Ambulatory Blood Pressure Response SNPs With Office Blood Pressure Responses to Candesartan in GERA II and to Losartan in SOPHIA

  Rank in GENRES   SNP          Chr   Position (Build 37)   Replication Results From GERA II (N=198)   Replication Results From SOPHIA (N=372)                                                                                          
  ---------------- ------------ ----- --------------------- ------------------------------------------ ----------------------------------------- ------ ------ ------ ---------- ---------- ----- ------ ----- ------ ------ ---------- ----------
  1                rs1370555    15    97 049 985            C/T                                        0.51                                      1.00   SBP    −0.3   0.84       Same       T/C   0.42   ---   SBP    0.2    0.76       Same
                                                                                                                                                 DBP    0.2    0.82   Opposite                           DBP   0.2    0.60   Same       
  2                rs7086428    10    130 778 452           A/G                                        0.35                                      ---    SBP    −1.6   0.22       Opposite   A/G   0.36   ---   SBP    0.7    0.26       Same
                                                                                                                                                 DBP    −0.6   0.55   Opposite                           DBP   0.1    0.74   Same       
  3                rs4953045    2     44 268 800            C/T                                        0.24                                      0.90   SBP    −1.9   0.25       Same       C/T   0.28   ---   SBP    −1.3   0.06       Same
                                                                                                                                                 DBP    −2.1   0.10   Same                               DBP   0.2    0.77   Opposite   
  4                rs711513     7     109 368 769           A/G                                        0.70                                      0.98   SBP    −0.2   0.91       Opposite   G/A   0.39   ---   SBP    −0.7   0.29       Same
                                                                                                                                                 DBP    −0.7   0.51   Opposite                           DBP   −0.3   0.49   Same       
  5                rs12814605   12    63 438 145            C/T                                        0.87                                      0.99   SBP    −0.8   0.69       Opposite   T/C   0.13   ---   SBP    −1.0   0.29       Same
                                                                                                                                                 DBP    0.7    0.62   Same                               DBP   −1.0   0.14   Same       
  6                rs2279989    9     1 041 524             A/G                                        0.06                                      0.98   SBP    3.0    0.32       Opposite   A/G   0.06   ---   SBP    1.3    0.34       Opposite
                                                                                                                                                 DBP    1.6    0.47   Opposite                           DBP   0.1    0.93   Opposite   
  7                rs7597606    2     41 836 313            C/T                                        0.58                                      0.96   SBP    −0.6   0.65       Same       T/C   0.42   ---   SBP    0.1    0.86       Same
                                                                                                                                                 DBP    −0.8   0.43   Same                               DBP   0.2    0.72   Same       
  8                rs1559557    2     57 332 673            C/T                                        0.38                                      0.99   SBP    0.1    0.92       Same       C/T   0.37   ---   SBP    −0.6   0.34       Opposite
                                                                                                                                                 DBP    −0.3   0.77   Opposite                           DBP   −0.7   0.15   Opposite   
  9                rs1432232    2     137 799 664           G/T                                        0.71                                      ---    SBP    2.8    0.06       Opposite   T/G   0.26   ---   SBP    −0.3   0.64       Opposite
                                                                                                                                                 DBP    1.8    0.11   Opposite                           DBP   −0.6   0.27   Opposite   
  10               rs1993802    3     110 595 402           C/T                                        0.08                                      ---    SBP    1.4    0.60       Opposite   C/T   0.10   ---   SBP    0.3    0.75       Opposite
                                                                                                                                                 DBP    1.4    0.48   Opposite                           DBP   −0.5   0.46   Same       
  11               rs12602832   17    42 396 896            NA                                                                                                                              T/C   0.06   ---   SBP    −0.6   0.67       Same
                                                                                                                                                                                                         DBP   −0.5   0.57   Same       
  12               rs2038912    10    20 207 349            C/T                                        0.42                                      1.00   SBP    1.5    0.26       Opposite   C/T   0.42   ---   SBP    −0.8   0.22       Same
                                                                                                                                                 DBP    0.8    0.41   Opposite                           DBP   −0.4   0.45   Same       
  13               rs4759885    12    131 736 813           C/T                                        0.58                                      0.99   SBP    1.6    0.20       Opposite   T/C   0.34   ---   SBP    −0.4   0.48       Opposite
                                                                                                                                                 DBP    1.0    0.31   Opposite                           DBP   −0.6   0.21   Opposite   
  14               rs771574     3     101 620 682           A/G                                        0.63                                      1.00   SBP    −0.3   0.84       Opposite   G/A   0.27   ---   SBP    0.5    0.51       Opposite
                                                                                                                                                 DBP    −0.0   0.99   Opposite                           DBP   0.4    0.40   Opposite   
  15               rs10754459   1     245 785 508           NA                                                                                                                              C/T   0.22   ---   SBP    1.2    0.14       Opposite
                                                                                                                                                                                                         DBP   0.9    0.12   Opposite   
  16               rs1392874    4     101 466 820           A/C                                        0.43                                      0.99   SBP    −1.1   0.43       Same       A/C   0.39   ---   SBP    0.6    0.38       Opposite
                                                                                                                                                 DBP    −0.4   0.71   Same                               DBP   0.0    0.97   Opposite   
  17               rs1357365    17    34 436 532            A/G                                        0.30                                      1.00   SBP    −0.3   0.84       Opposite   A/G   0.35   ---   SBP    0.2    0.81       Same
                                                                                                                                                 DBP    0.1    0.95   Same                               DBP   0.4    0.44   Same       
  18               rs3814995    19    36 342 212            C/T                                        0.68                                      0.19   SBP    7.1    0.03       Same       T/C   0.28   ---   SBP    −0.9   0.19       Same
                                                                                                                                                 DBP    5.9    0.02   Same                               DBP   −1.1   0.03   Same       
  19               rs11841583   13    31 495 179            A/G                                        0.13                                      0.83   SBP    0.6    0.78       Opposite   A/G   0.05   ---   SBP    2.6    0.07       Opposite
                                                                                                                                                 DBP    0.7    0.67   Opposite                           DBP   0.8    0.43   Opposite   
  20               rs17271855   19    5 524 721             C/T                                        0.83                                      0.88   SBP    −2.2   0.23       Opposite   T/C   0.20   ---   SBP    −0.0   0.99       Same
                                                                                                                                                 DBP    −0.5   0.72   Opposite                           DBP   −0.1   0.81   Same       

The loci are listed in the order of their rank in GENRES. CA indicates coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NA, not analyzed; NCA, noncoded allele; *r*^2^ imp, *r*^2^ values for imputed SNPs; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

###### 

Replication Analysis of the Best GENRES Bisoprolol 24‐H Ambulatory Blood Pressure Response SNPs With Ambulatory 24‐H Blood Pressure Responses to Atenolol in PEAR

  Rank in GENRES   SNP          Chr   Position (Build 37)   Replication Results From PEAR (N=192 to 193)                                   
  ---------------- ------------ ----- --------------------- ---------------------------------------------- ------ ------ ------ ---------- ----------
  1                rs2514036    11    67 415 054            C/T                                            0.18   SBP    0.7    0.58       Opposite
                                                                                                           DBP    0.5    0.56   Opposite   
  2                rs7268800    20    38 580 738            G/A                                            0.37   SBP    −0.5   0.61       Same
                                                                                                           DBP    −0.9   0.14   Same       
  3                rs12967284   18    12 532 098            T/C                                            0.34   SBP    0.1    0.90       Same
                                                                                                           DBP    0.2    0.75   Same       
  4                rs4357510    1     192 612 394           A/C                                            0.06   SBP    1.5    0.37       Opposite
                                                                                                           DBP    1.0    0.35   Opposite   
  5                rs2506143    10    33 468 169            G/A                                            0.17   SBP    1.3    0.28       Same
                                                                                                           DBP    0.9    0.26   Same       
  6                rs2029870    6     164 888 366           A/G                                            0.21   SBP    −0.6   0.61       Same
                                                                                                           DBP    0.2    0.84   Opposite   
  7                rs7984003    13    82 866 573            T/C                                            0.18   SBP    2.1    0.07       Same
                                                                                                           DBP    0.5    0.52   Same       
  8                rs11777699   8     6 714 699             G/A                                            0.45   SBP    −0.0   0.99       Same
                                                                                                           DBP    0.2    0.75   Opposite   
  9                rs10519585   5     118 676 529           C/T                                            0.35   SBP    −0.2   0.79       Same
                                                                                                           DBP    0.3    0.63   Opposite   
  10               rs6501061    16    8 092 171             C/T                                            0.04   SBP    1.4    0.55       Same
                                                                                                           DBP    0.7    0.65   Same       
  11               rs16918900   8     54 147 242            T/C                                            0.04   SBP    0.1    0.97       Opposite
                                                                                                           DBP    0.6    0.67   Opposite   
  12               rs2194860    4     109 948 511           A/G                                            0.16   SBP    0.2    0.87       Same
                                                                                                           DBP    −0.3   0.72   Opposite   
  13               rs2765115    13    24 529 399            G/A                                            0.13   SBP    −2.2   0.14       Same
                                                                                                           DBP    −0.4   0.71   Same       
  14               rs17642669   5     140 628 277           G/A                                            0.05   SBP    −1.5   0.48       Same
                                                                                                           DBP    0.4    0.80   Opposite   
  15               rs7895038    10    2 432 266             T/C                                            0.47   SBP    0.0    0.98       Opposite
                                                                                                           DBP    0.3    0.60   Same       
  16               rs150210     21    19 362 312            C/T                                            0.25   SBP    1.1    0.30       Opposite
                                                                                                           DBP    0.6    0.43   Opposite   
  17               rs10910862   1     181 045 421           T/C                                            0.06   SBP    0.2    0.93       Opposite
                                                                                                           DBP    −0.1   0.96   Same       
  18               rs2148117    10    27 213 946            C/T                                            0.05   SBP    −0.6   0.80       Same
                                                                                                           DBP    0.2    0.88   Opposite   
  19               rs1150433    3     163 653 210           T/C                                            0.21   SBP    0.4    0.71       Opposite
                                                                                                           DBP    0.0    0.98   Same       
  20               rs969981     17    63 818 989            T/C                                            0.23   SBP    0.2    0.85       Opposite
                                                                                                           DBP    0.1    0.86   Opposite   

The loci are listed in the order of their rank in GENRES. All SNPs in this table were genotyped. CA indicates coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NCA, non‐coded allele; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

###### 

Replication Analysis of the Best GENRES Hydrochlorothiazide 24‐H Ambulatory Blood Pressure Response SNPs With Office Blood Pressure Responses to Hydrochlorothiazide in GERA I and With 24‐H Ambulatory Blood Pressure Responses in PEAR

  Rank in GENRES   SNP          Chr   Position (Build 37)   Replication Results From GERA I (N=196)   Replication Results From PEAR (N=190 to 193)                                                                                          
  ---------------- ------------ ----- --------------------- ----------------------------------------- ---------------------------------------------- ------ ------ ------ ---------- ---------- ----- ------ ----- ------ ------ ---------- ----------
  1                rs4867623    5     170 071 480           NA                                                                                                                                  T/C   0.14   ---   SBP    −0.8   0.49       Same
                                                                                                                                                                                                             DBP   −0.4   0.68   Same       
  1                rs4868010    5     170 092 760           T/G                                       0.13                                           0.95   SBP    −1.8   0.28       Same       T/G   0.11   ---   SBP    −1.6   0.23       Same
                                                                                                                                                     DBP    −0.5   0.67   Same                               DBP   −1.1   0.29   Same       
  2                rs321320     6     45 702 779            C/T                                       0.22                                           0.82   SBP    1.1    0.49       Opposite   C/T   0.22   ---   SBP    0.4    0.71       Opposite
                                                                                                                                                     DBP    −0.8   0.48   Same                               DBP   −0.5   0.52   Same       
  2                rs321329     6     45 722 988            T/C                                       0.46                                           0.72   SBP    −2.0   0.16       Same       T/C   0.44   ---   SBP    −0.7   0.47       Same
                                                                                                                                                     DBP    −2.3   0.03   Same                               DBP   −0.4   0.54   Same       
  3                rs11006074   10    59 941 452            G/A                                       0.13                                           0.94   SBP    4.3    0.01       Same       G/A   0.17   ---   SBP    −1.6   0.16       Opposite
                                                                                                                                                     DBP    1.9    0.14   Same                               DBP   −0.8   0.37   Opposite   
  4                rs3117915    13    22 605 580            G/A                                       0.23                                           0.66   SBP    −0.4   0.80       Same       G/A   0.29   ---   SBP    −0.3   0.73       Same
                                                                                                                                                     DBP    0.4    0.74   Opposite                           DBP   0.1    0.86   Opposite   
  5                rs7821547    8     13 541 779            T/C                                       0.18                                           0.94   SBP    −1.7   0.30       Opposite   T/C   0.26   ---   SBP    −0.9   0.41       Opposite
                                                                                                                                                     DBP    −0.9   0.47   Opposite                           DBP   −0.1   0.94   Opposite   
  6                rs3825926    15    101 445 441           NA                                                                                                                                  A/G   0.01   ---   SBP    3.6    0.36       Same
                                                                                                                                                                                                             DBP   5.1    0.08   Same       
  7                rs2056531    17    47 283 058            T/C                                       0.16                                           ---    SBP    −0.7   0.69       Opposite   T/C   0.20   ---   SBP    1.8    0.09       Same
                                                                                                                                                     DBP    −1.1   0.42   Opposite                           DBP   1.6    0.05   Same       
  8                rs6977301    7     42 497 247            A/G                                       0.07                                           0.88   SBP    −1.2   0.65       Opposite   A/G   0.07   ---   SBP    −1.2   0.51       Opposite
                                                                                                                                                     DBP    −1.3   0.48   Opposite                           DBP   −0.5   0.68   Opposite   
  9                rs1553009    7     45 908 994            A/G                                       0.21                                           1.00   SBP    −0.9   0.54       Opposite   A/G   0.22   ---   SBP    0.0    0.97       Opposite
                                                                                                                                                     DBP    −2.1   0.05   Opposite                           DBP   −0.5   0.55   Opposite   
  10               rs2776906    6     37 431 757            T/C                                       0.26                                           0.99   SBP    0.1    0.94       Same       T/C   0.33   ---   SBP    0.6    0.52       Same
                                                                                                                                                     DBP    −1.1   0.26   Opposite                           DBP   0.7    0.32   Same       
  11               rs964132     19    19 243 175            T/C                                       0.03                                           0.55   SBP    −5.6   0.28       Opposite   T/C   0.02   ---   SBP    1.7    0.62       Same
                                                                                                                                                     DBP    −1.8   0.63   Opposite                           DBP   1.1    0.66   Same       
  12               rs158210     5     55 737 637            T/C                                       0.11                                           0.80   SBP    0.5    0.83       Opposite   A/G   0.10   ---   SBP    3.5    0.02       Opposite
                                                                                                                                                     DBP    0.4    0.79   Opposite                           DBP   3.0    0.01   Opposite   
  13               rs1324210    9     114 791 150           A/G                                       0.16                                           0.63   SBP    −3.2   0.13       Opposite   A/G   0.18   ---   SBP    −1.8   0.10       Opposite
                                                                                                                                                     DBP    −2.2   0.16   Opposite                           DBP   −1.2   0.16   Opposite   
  14               rs6546025    2     63 923 561            G/A                                       0.22                                           0.97   SBP    0.3    0.84       Opposite   G/A   0.22   ---   SBP    1.9    0.06       Opposite
                                                                                                                                                     DBP    −0.1   0.94   Same                               DBP   1.7    0.03   Opposite   
  15               rs11059985   12    129 347 891           A/G                                       0.25                                           0.46   SBP    −0.6   0.77       Opposite   A/G   0.26   ---   SBP    0.8    0.40       Same
                                                                                                                                                     DBP    −0.1   0.94   Opposite                           DBP   0.7    0.36   Same       
  16               rs3799369    6     25 912 634            C/T                                       0.11                                           0.95   SBP    0.9    0.65       Same       G/A   0.10   ---   SBP    1.0    0.51       Same
                                                                                                                                                     DBP    −0.0   1.00   Opposite                           DBP   0.9    0.41   Same       
  17               rs17099050   14    100 255 923           G/T                                       0.04                                           0.87   SBP    −2.6   0.41       Opposite   G/T   0.04   ---   SBP    1.5    0.48       Same
                                                                                                                                                     DBP    −2.8   0.23   Opposite                           DBP   1.6    0.29   Same       
  18               rs329668     11    133 795 219           NA                                                                                                                                  T/C   0.13   ---   SBP    0.1    0.94       Same
                                                                                                                                                                                                             DBP   0.0    1.00   Same       
  19               rs776472     7     114 352 862           C/T                                       0.44                                           0.92   SBP    −0.6   0.61       Same       G/A   0.42   ---   SBP    1.1    0.21       Opposite
                                                                                                                                                     DBP    −1.7   0.05   Same                               DBP   1.1    0.10   Opposite   
  20               rs1922117    12    63 789 836            G/T                                       0.29                                           0.99   SBP    0.0    0.98       Opposite   G/T   0.34   ---   SBP    1.0    0.29       Opposite
                                                                                                                                                     DBP    0.5    0.62   Opposite                           DBP   0.5    0.49   Opposite   

The loci are listed in the order of their rank in GENRES. CA indicates coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; NA, not analyzed; NCA, non‐coded allele; *r*^2^ imp, *r*^2^ values for imputed SNPs; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

Of the 60 SNPs with the strongest associations to losartan, bisoprolol, or hydrochlorothiazide responses in GENRES (Tables [2](#tbl02){ref-type="table"}, [3](#tbl03){ref-type="table"} and [5](#tbl05){ref-type="table"}), no SNP reached the Bonferroni‐corrected level of significance (2.5×10^−4^). Only 1 SNP (rs3814995 on chromosome 19) emerged that gave a 2‐sided *P* value \<0.05 (suggestive significance level), with the same direction of BP effect, for both systolic and diastolic blood pressure responses to a particular drug in 2 other studies ([Table 7](#tbl07){ref-type="table"}). Accordingly, rs3814995 was associated with systolic (*P*=2.0×10^−5^) and diastolic (*P*=5.1×10^−4^) BP responses to losartan in GENRES, with systolic (*P*=0.03) and diastolic (*P*=0.02) BP responses in GERA II, and diastolic BP responses (*P*=0.03) in SOPHIA ([Table 7](#tbl07){ref-type="table"}); there was a trend toward association for systolic BP response in SOPHIA (*P*=0.19). The SNP rs3814995 corresponds to a Glu117Lys missense mutation in the *NPHS1* gene coding for the protein nephrin.

Third Step: Meta‐Analyses Based on GENRES, PEAR, GERA I, GERA II, and SOPHIA Data
---------------------------------------------------------------------------------

A meta‐analysis employing inverse‐variance model with fixed effects was carried out using SNP data from GENRES, GERA I, GERA II, PEAR, and SOPHIA studies ([Table 10](#tbl10){ref-type="table"}). *P* values \<1×10^−5^ were considered to indicate a suggestive association; no SNP reached the genome‐wide level of significance (5×10^−8^).

###### 

Meta‐Analysis of Blood Pressure Responses to Angiotensin Receptor Antagonists, β‐Receptor Blockers, and Hydrochlorothiazide

  SNP                                Chr   Position    Nearest Gene     CA/NCA   Meta‐Analysis   Discovery Study   Replication Study                                                          
  ---------------------------------- ----- ----------- ---------------- -------- --------------- ----------------- ------------------- --------- -------- --------- --------- ------ -------- ------
  Angiotensin receptor antagonists                                                                                                               GENRES             GERA II          SOPHIA   
  SBP response                                                                                                                                                                                
  rs4953045                          2     44268800    *LRPPRC*         G/A      775             0.26              −2.4                5.1E‐07   −3.5     1.1E‐06   −1.9      0.25   −1.3     0.06
  DBP response                                                                                                                                                                                
  rs12814605                         12    63438145    *AVPR1A*         A/G      775             0.14              −1.9                6.4E‐06   −3.0     2.3E‐06   −0.7      0.62   −1.0     0.14
  β‐Receptor blockers                                                                                                                            GENRES             PEAR                      
  SBP response                                                                                                                                                                                
  rs7984003                          13    82866573    Intergenic       A/G      438             0.23              2.9                 7.8E‐07   3.1      5.4E‐06   2.1       0.07            
  rs2765115                          13    24529399    *SPATA13*        G/A      440             0.15              −3.3                3.6E‐06   −3.7     1.2E‐05   −2.2      0.14            
  DBP response                                                                                                                                                                                
  rs7268800                          20    38580738    lincRNA          G/A      440             0.40              −1.6                8.6E‐07   −1.9     2.1E‐06   −0.9      0.14            
  Hydrochlorothiazide                                                                                                                            GENRES             GERA I           PEAR     
  SBP response                                                                                                                                                                                
  rs3825926                          15    101445441   *ALDH1A3*        A/G      399             0.03              6.7                 5.6E‐06   7.3      1.0E‐05   NA        NA     3.6      0.36
  DBP response                                                                                                                                                                                
  rs4867623                          5     170071480   *KCNIP1*         A/G      398             0.18              −2.1                1.5E‐06   −2.6     3.7E‐07   NA        NA     −0.4     0.68
  rs321329                           6     45722988    *CLIC5, RUNX2*   A/G      595             0.42              −1.5                2.3E‐06   −1.7     1.1E‐05   −2.3      0.03   −0.4     0.54
  rs321320                           6     45702779    *CLIC5, RUNX2*   G/A      594             0.17              −1.9                8.5E‐06   −2.5     2.3E‐06   −0.8      0.48   −0.5     0.52

The top 20 GENRES single‐nucleotide polymorphisms of each drug were analyzed using GENRES, GERA1, GERA II, PEAR, and SOPHIA data. Single‐nucleotide polymorphisms with significance level \<1×10^−5^ are shown. Physical positions are given in build 37 coordinates and β values in mm Hg. CA indicates coded allele; CAF, coded allele frequency; Chr, chromosome; DBP, diastolic blood pressure; lincRNA, long intergenic noncoding RNA; N, total number of subjects in meta‐analysis; NA, data not available; NCA, noncoded allele; SBP, systolic blood pressure; SNP, single‐nucleotide polymorphism.

Of the top 20 SNPs associated with losartan responses in the GENRES Study, rs4953045 on chromosome 2 was associated with BP response (*P*=5.1×10^−7^) and rs12814605 on chromosome 12 with diastolic BP response (*P*=6.4×10^−6^) in the meta‐analysis utilizing responses to losartan in SOPHIA and candesartan in GERA II (Tables [10](#tbl10){ref-type="table"} and [11](#tbl11){ref-type="table"}). The closest gene to the intergenic SNP rs4953045 is *LRPPRC*, which is located 46 kbp apart from it and codes for mitochondrial leucine‐rich PPR motif‐containing protein. rs12814605 is likewise an intergenic variant, located approximately 100 kb apart from the closest protein‐coding genes *AVPR1A* (arginine vasopressin receptor 1A) and *PPM1H* (Mg^2+^/Mn^2+^ dependent protein phosphatase 1H). However, the slightly higher *P* value for this SNP in the meta‐analysis than in the discovery study ([Table 10](#tbl10){ref-type="table"}) renders the significance of this finding uncertain.

###### 

Meta‐Analysis of Blood Pressure Responses to Angiotensin Receptor Antagonists

  SNP                                 Chr   CA   NCA   N     CAF    β      SE    *P* Value   Direction of β (GENRES/GERA II/SOPHIA)
  ----------------------------------- ----- ---- ----- ----- ------ ------ ----- ----------- ----------------------------------------
  Systolic blood pressure response                                                           
  rs4953045                           2     G    A     775   0.26   −2.4   0.5   5.1E‐07     − − −
  rs3814995                           19    A    G     774   0.32   −2.0   0.5   1.5E‐05     − − −
  rs7086428                           10    A    G     775   0.37   1.6    0.4   2.1E‐04     \+ − +
  rs7597606                           2     A    G     774   0.41   1.5    0.4   3.2E‐04     \+ + +
  rs12814605                          12    A    G     775   0.14   −2.2   0.6   3.5E‐04     − + −
  rs1370555                           15    G    A     775   0.49   −1.3   0.4   2.1E‐03     − − −
  rs1993802                           3     G    A     775   0.14   −1.9   0.6   2.7E‐03     − + +
  rs711513                            7     G    A     772   0.37   −1.3   0.4   3.1E‐03     − + −
  rs12602832                          17    A    G     574   0.11   −2.1   0.7   4.0E‐03     − ? −
  rs2038912                           10    A    G     775   0.54   1.1    0.4   9.0E‐03     \+ − +
  rs1357365                           17    A    G     775   0.29   1.1    0.5   1.7E‐02     \+ − +
  rs1559557                           2     G    A     775   0.35   1.1    0.5   1.8E‐02     \+ + −
  rs771574                            3     G    A     775   0.27   −1.1   0.5   2.9E‐02     − + +
  rs11841583                          13    A    G     775   0.09   −1.7   0.8   2.9E‐02     − + +
  rs2279989                           9     A    G     775   0.08   −1.6   0.8   3.7E‐02     − + +
  rs17271855                          19    A    G     775   0.19   −1.1   0.5   4.8E‐02     − + −
  rs1432232                           2     A    C     775   0.23   1.0    0.5   5.0E‐02     \+ −
  rs4759885                           12    G    A     775   0.57   −0.7   0.4   9.2E‐02     − + +
  rs1392874                           4     A    C     775   0.42   −0.7   0.4   9.8E‐02     − +
  rs10754459                          1     G    A     575   0.26   −0.7   0.5   1.6E‐01     − ? +
  Diastolic blood pressure response                                                          
  rs12814605                          12    A    G     775   0.14   −1.9   0.4   6.4E‐06     − − −
  rs3814995                           19    A    G     774   0.32   −1.4   0.3   1.1E‐05     − − −
  rs12602832                          17    A    G     574   0.11   −2.1   0.5   4.2E‐05     − ? −
  rs1370555                           15    G    A     775   0.49   −1.1   0.3   1.0E‐04     − + −
  rs1993802                           3     G    A     775   0.14   −1.7   0.4   2.1E‐04     − + −
  rs711513                            7     G    A     772   0.37   −1.1   0.3   2.6E‐04     − + −
  rs2279989                           9     A    G     775   0.08   −1.9   0.5   4.0E‐04     − + +
  rs1357365                           17    A    G     775   0.29   1.2    0.3   4.5E‐04     \+ + +
  rs4953045                           2     G    A     775   0.26   −1.2   0.3   6.0E‐04     − +
  rs2038912                           10    A    G     775   0.54   1.0    0.3   6.2E‐04     \+ − +
  rs1392874                           4     A    C     775   0.42   −1.0   0.3   1.2E‐03     − +
  rs17271855                          19    A    G     775   0.19   −1.2   0.4   2.3E‐03     − + −
  rs7597606                           2     A    G     774   0.41   0.9    0.3   4.0E‐03     \+ + +
  rs11841583                          13    A    G     775   0.09   −1.6   0.6   4.5E‐03     − + +
  rs7086428                           10    A    G     775   0.37   0.8    0.3   1.3E‐02     \+ − +
  rs771574                            3     G    A     775   0.27   −0.8   0.4   1.7E‐02     − + +
  rs10754459                          1     G    A     575   0.26   −0.9   0.4   1.7E‐02     − ? +
  rs4759885                           12    G    A     775   0.57   −0.6   0.3   7.0E‐02     − + +
  rs1559557                           2     G    A     775   0.35   0.5    0.3   1.6E‐01     \+ −
  rs1432232                           2     A    C     775   0.23   0.5    0.4   2.1E‐01     \+ −

The best GENRES losartan 24‐h ambulatory blood pressure response SNPs were analyzed using GENRES, GERA II, and SOPHIA data. ? indicates data not available; CA, coded allele; CAF, weighed coded allele frequency; Chr, chromosome; N, total number of subjects in meta‐analysis; NCA, noncoded allele; SNP, single‐nucleotide polymorphism.

Next, a meta‐analysis of the 20 SNPs with the highest association scores with bisoprolol responses in GENRES was performed in conjunction with the PEAR Study, using 24‐hour ABP responses to atenolol for comparison (Tables [10](#tbl10){ref-type="table"} and [12](#tbl12){ref-type="table"}). Two SNPs on chromosome 13, rs7984003 (*P*=7.8×10^−7^) and rs2765115 (*P*=3.6×10^−6^) showed suggestive evidence of association when systolic ABP responses of both studies were analyzed. Two pseudogenes (*PTMAP* and *GYG1P2)* but no obvious protein‐coding gene candidates are located in the vicinity of rs7984003. Of the protein‐coding genes, *SPATA13* coding for spermatogenesis‐associated protein 13 lies closest (24 kbp) to rs2765115. A corresponding meta‐analysis of DBP responses to bisoprolol revealed an association to rs7268800 (*P*=8.6×10^−7^), which is an intergenic polymorphism, with 2 long intergenic non‐protein coding RNA species but no apparent candidate genes in its vicinity.

###### 

Meta‐Analysis of Blood Pressure Responses to β‐Receptor Blockers

  SNP                                 Chr   CA   NCA   N     CAF    β      SE    *P* Value   Direction of β (GENRES/PEAR)
  ----------------------------------- ----- ---- ----- ----- ------ ------ ----- ----------- ------------------------------
  Systolic blood pressure response                                                           
  rs7984003                           13    A    G     438   0.23   2.9    0.6   7.8E‐07     \+ +
  rs2765115                           13    G    A     440   0.15   −3.3   0.7   3.6E‐06     − −
  rs6501061                           16    G    A     440   0.08   4.1    0.9   1.2E‐05     \+ +
  rs2514036                           11    G    A     440   0.14   −3.1   0.7   2.1E‐05     − +
  rs2194860                           4     A    G     440   0.18   2.5    0.6   5.5E‐05     \+ +
  rs12967284                          18    A    G     440   0.28   2.0    0.5   1.1E‐04     \+ +
  rs2029870                           6     A    G     437   0.16   −2.5   0.7   2.0E‐04     − −
  rs7895038                           10    G    A     440   0.45   −1.8   0.5   2.6E‐04     − +
  rs10519585                          5     G    A     440   0.32   −1.8   0.5   3.7E‐04     − −
  rs969981                            17    A    G     439   0.18   −2.2   0.6   3.9E‐04     − +
  rs2506143                           10    G    A     440   0.12   2.6    0.8   5.5E‐04     \+ +
  rs2148117                           10    G    A     440   0.03   −5.1   1.5   8.3E‐04     − −
  rs10910862                          1     A    G     440   0.06   −3.5   1.1   1.1E‐03     − +
  rs150210                            21    G    A     440   0.27   −1.7   0.5   1.2E‐03     − +
  rs7268800                           20    G    A     440   0.40   −1.6   0.5   1.2E‐03     − −
  rs17642669                          5     G    A     440   0.06   −3.3   1.1   2.4E‐03     − −
  rs4357510                           1     A    C     440   0.06   −2.9   1.0   2.6E‐03     − +
  rs11777699                          8     G    A     439   0.49   −1.4   0.5   5.1E‐03     − −
  rs1150433                           3     A    G     440   0.16   −1.9   0.7   5.2E‐03     − +
  rs16918900                          8     A    G     440   0.03   −3.7   1.6   2.3E‐02     − +
  Diastolic blood pressure response                                                          
  rs7268800                           20    G    A     440   0.40   −1.6   0.3   8.6E‐07     − −
  rs2506143                           10    G    A     440   0.12   2.2    0.5   1.0E‐05     \+ +
  rs7984003                           13    A    G     438   0.23   1.7    0.4   1.4E‐05     \+ +
  rs12967284                          18    A    G     440   0.28   1.5    0.4   3.6E‐05     \+ +
  rs11777699                          8     G    A     439   0.49   −1.2   0.3   1.2E04      − +
  rs2029870                           6     A    G     437   0.16   −1.7   0.4   1.6E‐04     − +
  rs17642669                          5     G    A     440   0.06   −2.7   0.7   2.0E‐04     − +
  rs10910862                          1     A    G     440   0.06   −2.6   0.7   2.3E‐04     − −
  rs2765115                           13    G    A     440   0.15   −1.8   0.5   2.4E‐04     − −
  rs10519585                          5     G    A     440   0.32   −1.2   0.3   3.4E‐04     − +
  rs2514036                           11    G    A     440   0.14   −1.7   0.5   4.4E‐04     − +
  rs1150433                           3     A    G     440   0.16   −1.5   0.5   8.0E‐04     − −
  rs4357510                           1     A    C     440   0.06   −2.1   0.7   1.2E‐03     − +
  rs2194860                           4     A    G     440   0.18   1.4    0.4   1.4E‐03     \+ −
  rs6501061                           16    G    A     440   0.08   2.0    0.6   1.8E‐03     \+ +
  rs7895038                           10    G    A     440   0.45   −1.0   0.3   2.5E‐03     − −
  rs2148117                           10    G    A     440   0.03   −3.0   1.0   4.0E‐03     − +
  rs16918900                          8     A    G     440   0.03   −3.0   1.1   5.9E‐03     − +
  rs150210                            21    G    A     440   0.27   −0.9   0.4   1.1E‐02     − +
  rs969981                            17    A    G     439   0.18   −1.1   0.4   1.3E‐02     − +

The best GENRES bisoprolol 24‐h ambulatory blood pressure response SNPs were analyzed using GENRES and PEAR data. CA indicates coded allele; CAF, weighed coded allele frequency; Chr, chromosome; N, total number of subjects in meta‐analysis; NCA, non‐coded allele; SNP, single‐nucleotide polymorphism.

Finally, we carried out a similar meta‐analysis with the hydrochlorothiazide response data, using 24‐hour ABP responses in PEAR and OBP responses in GERA I for comparison (Tables [10](#tbl10){ref-type="table"} and [13](#tbl13){ref-type="table"}). rs3825926 on chromosome 15 was found to associate with systolic BP responses (*P*=5.6×10^−6^; GERA I data lacking). This SNP is located in the intron of the *ALDH1A3* gene coding for aldehyde dehydrogenase 1 family member A3, and is 14 kbp apart from the *LRRK1* gene coding for leucine‐rich repeat kinase 1. A corresponding meta‐analysis of diastolic BP responses revealed 3 suggestive associations to 3 SNPs ([Table 10](#tbl10){ref-type="table"}). rs4867623 is an intronic variant of *KCNIP1* coding for potassium (Kv) channel interacting protein 1; however, a higher *P* value was obtained in the meta‐analysis than in the discovery sample ([Table 10](#tbl10){ref-type="table"}). rs321329 and rs321320 are 2 adjacent intergenic variants on chromosome 6, lying ≈90 kbp of *RUNX2* encoding the runt‐related transcription factor 2 and ≈145 kb from *CLIC5* encoding the chloride intracellular channel 5.

###### 

Meta‐Analysis of Blood Pressure Responses to Hydrochlorothiazide

  SNP                                 Chr   CA   NCA   N     CAF    β      SE    *P* Value   Direction of β (GENRES/GERA I/PEAR)
  ----------------------------------- ----- ---- ----- ----- ------ ------ ----- ----------- -------------------------------------
  Systolic blood pressure response                                                           
  rs3825926                           15    A    G     399   0.03   6.7    1.5   5.6E‐06     \+ ? +
  rs3799369                           6     G    A     595   0.11   2.7    0.7   6.6E‐05     \+ + +
  rs321329                            6     A    G     595   0.42   −1.8   0.5   7.3E‐05     − − −
  rs11059985                          12    A    G     594   0.28   2.0    0.5   1.0E‐04     \+ − +
  rs2776906                           6     A    G     595   0.34   1.8    0.5   1.1E‐04     \+ + +
  rs329668                            11    A    G     398   0.13   2.5    0.7   3.1E‐04     \+ ? +
  rs2056531                           17    A    G     595   0.15   2.2    0.6   8.3E‐04     \+ − +
  rs6977301                           7     A    G     595   0.08   2.7    0.8   1.1E‐03     \+ −
  rs4868010                           5     A    C     594   0.14   −2.0   0.7   2.4E‐03     − − −
  rs776472                            7     G    A     595   0.43   −1.3   0.4   2.6E‐03     − +
  rs17099050                          14    C    A     595   0.04   3.7    1.2   2.6E‐03     \+ − +
  rs964132                            19    A    G     595   0.04   4.0    1.3   3.0E‐03     \+ − +
  rs11006074                          10    G    A     595   0.14   1.9    0.6   3.2E‐03     \+ + −
  rs321320                            6     G    A     594   0.17   −1.7   0.6   5.6E‐03     − + +
  rs4867623                           5     A    G     398   0.18   −1.8   0.7   6.3E‐03     − ? −
  rs3117915                           13    G    A     595   0.23   −1.4   0.5   1.1E‐02     − − −
  rs1324210                           9     A    G     595   0.23   1.4    0.5   1.1E‐02     \+ −
  rs1553009                           7     A    G     595   0.16   1.5    0.6   1.7E‐02     \+ −
  rs158210                            5     A    G     595   0.10   −1.8   0.7   1.9E‐02     − + +
  rs7821547                           8     A    G     595   0.23   1.2    0.5   2.4E‐02     \+ −
  rs1922117                           12    C    A     592   0.35   −1.0   0.5   2.7E‐02     − + +
  rs6546025                           2     G    A     595   0.23   −0.6   0.5   2.1E‐01     − + +
  Diastolic blood pressure response                                                          
  rs4867623                           5     A    G     398   0.18   −2.1   0.4   1.5E‐06     − ? −
  rs321329                            6     A    G     595   0.42   −1.5   0.3   2.3E‐06     − − −
  rs321320                            6     G    A     594   0.17   −1.9   0.4   8.5E‐06     − − −
  rs4868010                           5     A    C     594   0.14   −1.9   0.4   2.0E‐05     − − −
  rs2056531                           17    A    G     595   0.15   1.9    0.5   2.2E‐05     \+ − +
  rs964132                            19    A    G     595   0.04   3.6    0.9   5.8E‐05     \+ − +
  rs3825926                           15    A    G     399   0.03   3.9    1.0   1.2E‐04     \+ ? +
  rs11006074                          10    G    A     595   0.14   1.7    0.4   1.6E‐04     \+ + −
  rs3117915                           13    G    A     595   0.23   −1.3   0.4   4.0E‐04     − + +
  rs7821547                           8     A    G     595   0.23   1.3    0.4   4.5E‐04     \+ −
  rs6977301                           7     A    G     595   0.08   1.9    0.6   6.2E‐04     \+ −
  rs17099050                          14    C    A     595   0.04   2.9    0.9   7.9E‐04     \+ − +
  rs776472                            7     G    A     595   0.43   −1.0   0.3   1.1E‐03     − +
  rs1922117                           12    C    A     592   0.35   −1.0   0.3   2.4E‐03     − + +
  rs329668                            11    A    G     398   0.13   1.4    0.5   2.8E‐03     \+ ? +
  rs2776906                           6     A    G     595   0.34   0.9    0.3   4.1E‐03     \+ − +
  rs3799369                           6     G    A     595   0.11   1.3    0.5   5.5E‐03     \+ − +
  rs6546025                           2     G    A     595   0.23   −0.9   0.3   7.4E‐03     − +
  rs1324210                           9     A    G     595   0.23   0.9    0.4   1.7E‐02     \+ −
  rs11059985                          12    A    G     594   0.28   0.8    0.4   2.1E‐02     \+ − +
  rs1553009                           7     A    G     595   0.16   0.9    0.4   3.3E‐02     \+ −
  rs158210                            5     A    G     595   0.10   −1.1   0.5   4.0E‐02     − + +

The best GENRES hydrochlorothiazide 24‐h ambulatory blood pressure response SNPs were analyzed using GENRES, GERA I, and PEAR data. ? indicates data not available; CA, coded allele; CAF, weighed coded allele frequency; Chr, chromosome; N, total number of subjects in meta‐analysis; NCA, noncoded allele; SNP, single‐nucleotide polymorphism.

Discussion
==========

The majority of the pharmacogenomic studies on essential hypertension carried out until now suffer from weaknesses in their design.^[@b7]^ The GENRES Study represents a careful attempt to avoid some of the most important problems. Accordingly, this study is prospective, placebo‐controlled, and rotational in nature, implying that every test subject received 4 different antihypertensive drugs as a 4 weeks′ monotherapy in a randomized order, with 4 intervening 4 weeks′ placebo periods. The use of the mean of 4 placebo periods increases the accuracy of the estimation of baseline BP levels. The performance of the GENRES study has been validated by a number of observations. For example, the within‐subject resemblance of BP responses, as analyzed by pairwise correlation matrixes, was found to be highest for responses to bisoprolol and losartan (*r*=0.32 to 0.39), followed by responses to amlodipine and hydrochlorothiazide (*r*=0.20 to 0.35), as would be expected.^[@b13]^ In addition, plasma renin activity was positively correlated with BP responses to losartan (*P* values 0.001 to 0.005) and bisoprolol (*P* values 0.03 to 0.17), and negatively with BP responses to hydrochlorothiazide (*P* values 0.01 to 0.07).^[@b17]^

There are several important limitations in the present study. First, an obvious methodological limitation of the GENRES study is the sample size of 228 individuals, resulting in insufficient power to detect effect sizes of 0.5 to 1 mm Hg, characteristic of gene loci revealed in genome‐wide association studies of complex diseases. For example, we calculated that in order to reach a power of 80% to detect an antihypertensive response in GENRES, an effect size of 4 mm Hg is needed for a SNP with a minor allele frequency of 0.30. It should be noted, however, that in carefully controlled pharmacogenetic studies, common polymorphisms with small effects on BP levels may well have larger effects on BP responsiveness. Second, the GENRES study included only males with mild‐to‐moderate hypertension. Third, since equipotent drug effects were not designed to be reached, less variability in responses to certain drugs may have affected our data. Fourth, it is to be emphasized that while ABP measurements were used in GENRES and PEAR, OBP measurements were carried out in SOPHIA, GERA I, and GERA II, which may have affected the meta‐analysis data.

Even using the strictly controlled experimental conditions in GENRES, we failed to identify pharmacogenomic associations of genome‐wide significance (*P*\<5×10^−8^), with the exception of 3 SNPs (rs2514036, rs948445, and rs2514037) reaching this value for bisoprolol responses. In fact, we consider this lack of stronger associations as the most significant finding of our study, because it emphasizes the importance of even larger samples of patients in studies with similar strict design. Furthermore, it is of note that upon listing of 80 different SNPs (20 for each drug, Tables [2](#tbl04){ref-type="table"} through [5](#tbl05){ref-type="table"}) showing the strongest associations to drug responses, we failed to identify any SNP common to more than a single drug class, supporting the notion that the genomic pathways regulating the BP‐lowering mechanisms of different classes of antihypertensive drugs are specific to each class of drugs.

A meta‐analysis using losartan response data from the GENRES and SOPHIA studies and candesartan data from the GERA II study revealed 2 gene loci of potential interest. rs4953035 showing association with systolic BP responses is located ≈46 kbp from *LRPPRC* coding for mitochondrial leucine‐rich PPR motif‐containing protein that is expressed in a variety of tissues, including the heart and kidney. There were also other SNPs within or close to *LRPPRC* that showed a significant association ([Table 3](#tbl03){ref-type="table"}). Another gene of note, *PPM1B* coding for Mg^2+^/Mn^2+^ dependent protein phosphatase, lies 126 kb from rs4953035. This gene may be involved in the cell cycle and is richly expressed (eg, in the heart). Recent data indicate that the phosphatase coded by *PPB1B* selectively modulates PPAR activity.^[@b22]^

In addition, based on ranking of strengths of associations of the various drug responses in GENRES and available replication studies, we found that 1 particular SNP, rs3814995, was significantly associated with responses to angiotensin receptor antagonists in the same direction in 3 separate studies. It is of note that even meta‐analysis of the rs3814995 data indicated *P* values close to the 1.0×10^−5^ ([Table 11](#tbl11){ref-type="table"}). This missense variant (NM_004646.3:c.349G\>A) maps within the coding region of the *NPHS1* gene and causes an amino acid substitution of glutamic acid to lysine (p.Glu117Lys) in the nephrin protein. The amino acid is conserved and the change is predicted to be probably damaging by PolyPhen2 (score: 0.999). The variant is relatively common, with a higher minor allele frequency in populations of European origin (0.30) compared to African Americans (0.09) (Exome Variant Server, <http://evs.gs.washington.edu/EVS/>). Nephrin is the principal structural protein of the glomerular podocytes, and mutations of *NPHS1* result in the congenital nephrotic syndrome of the Finnish type.^[@b23]--[@b25]^ Increased angiotensin II levels have been shown to result in decrease of renal nephrin expression in a hypertensive rat model.^[@b26]^ Interestingly, angiotensin blockers irbesartan^[@b27]^ and valsartan^[@b28]^ have been shown to attenuate the decrease of nephrin levels and to retard the development of albuminuria in diabetic spontaneously hypertensive rats. The p.Glu117Lys variant does not seem to associate with diabetic proteinuria or end‐stage renal disease in type 1 diabetic patients, although carriers of the minor allele had a later onset of diabetes than those with the wild‐type allele.^[@b29]^ Collectively, the present and previous findings should justify additional studies using samples and data from large long‐term clinical trials in which nephrin Glu117Lys genotypes are related to blood pressure responses to angiotensin receptor antagonists and to cardiovascular events.

When bisoprolol data were analyzed in the GENRES material only, we obtained the highest *P* values with genome‐wide significance (2.0×10^−8^, 2.1×10^−8^, and 4.1×10^−8^) for the tightly linked nearby SNPs rs2514036, rs948445, and rs2514037 present on chromosome 11. rs2514036 is an upstream regulatory region variant of *ACY3*, encoding aminoacylase III, while rs2514037 is an intronic variant of *ACY3*. rs948445, a missense variant mapping within the coding region of the *ACY3* gene, causes an amino acid substitution p.Arg8Gln, which is predicted by PolyPhen2 to be benign. There appears to be no data solidly linking *ACY3* to regulation of blood pressure. It is known to be abundantly expressed in kidney proximal tubules, where it may have role in deacetylating mercapturic acids, and to lesser extent in other tissues including brain and heart.^[@b30]^ Although β‐adrenergic receptors may be more abundant in epithelial cells of distal than proximal parts of the nephron (for review, see Ref. ^[@b31]^), cultured proximal tubular cells obtained from animal models have been reported to contain β‐1‐ and β‐2‐adrenergic receptors.^[@b32]--[@b33]^ Other genes next to rs2514036 include ALDH3B2 (15 kbp apart) coding for aldehyde dehydrogenase 3 family member B2 expressed mainly in salivary gland and placenta,^[@b34]^ and *TBX10* (8 kbp apart) coding for a member of the T‐box family of transcription factors involved in organogenesis and embryonic development. However, rs2514036 data were not at all replicated in the PEAR study using atenolol as the β‐blocker ([Table 8](#tbl08){ref-type="table"}). In the meta‐analysis combining atenolol data of PEAR, 3 SNPs provided suggestive associations. rs7984003 and rs7268800 appear to be intergenic variants, with no obvious candidate genes for BP regulation in their vicinity, but rs7984003 maps within an ENCODE transcription factor binding site (ERα_a). rs2765115 is likewise an intergenic variant located 24 kbp from *SPATA13* coding for spermatogenesis‐associated protein 13, also known as APC‐stimulated guanine nucleotide exchange factor 2 (ASEF2). ASEF2 appears to specifically activate Rho‐family GTPases and may thus influence a wide range of cellular functions, including smooth‐muscle contraction. It is also of interest that a genetic association study has suggested that *SPATA13‐AS1* (gene coding for an antisense RNA that overlaps *SPATA13*) may serve as a pharmacogenomic predictor of effectiveness of inhaled β‐agonists.^[@b35]^

In the meta‐analysis of association with hydrochlorothiazide responsiveness, 3 different gene loci were identified that showed *P* values \<1.0×10^−5^ when replication data from GERA I and/or PEAR studies were used ([Table 10](#tbl10){ref-type="table"}). rs3825926 is of interest because the genotype‐related β values for thiazide responses were the highest in both GENRES and PEAR (Tables [5](#tbl05){ref-type="table"} and [9](#tbl09){ref-type="table"}); unfortunately, it could not be analyzed in GERA I. This SNP represents an intronic variant of *ALDH1A3*, coding for aldehyde dehydrogenase 1 family member A3. This gene is expressed in a variety of tissues including retina and kidney, and mutations of *ALDH1A3* are known to result in anophthalmia or microopthalmia.^[@b36]^ Another SNP, rs321329, deserves note since responses to hydrochlorothiazide followed a logical pattern (although *P* value remained nonsignificant in PEAR; [Table 9](#tbl09){ref-type="table"}) in all 3 studies. It should, however, be pointed out that the SNP rs321329 was not the top SNP of that locus in GENRES and the top SNP rs321320 showed no evidence of replication in GERA I or in PEAR ([Table 9](#tbl09){ref-type="table"}). The closest candidate genes, located 90 to 145 kbp from this SNP, include *RUNX2*, encoding a transcription factor involved in skeletal morphogenesis, and *CLIC5*, encoding the chloride intracellular channel protein 5. *CLIC5* is expressed (except in placenta and cochlea) in renal glomerular podocytes and endothelial cells, and is postulated to function in the maintenance of glomerular and podocyte architecture.^[@b37]^ It is not known, however, whether the *CLIC5* channel plays any role in thiazide action.

Certain general delineations of our findings should be recapitulated. First, none of the 80 SNPs (20 for each drug) listed in Tables [2](#tbl04){ref-type="table"} through [5](#tbl05){ref-type="table"} proved to give a hit when compared to the list of \>40 hypertension candidate loci^[@b6]^ derived from genome‐wide association studies of essential hypertension. Second, the association of the *NPHS1* (nephrin) gene Glu117Lys variant with losartan responsiveness is of interest in view of the experimental findings linking together angiotensin II levels, angiotensin II receptor blockers, nephrin expression, and development of albuminuria. Third, 2 different members of the aldehyde dehydrogenase (ALDH) gene family got some support as candidate genes, 1 for bisoprolol (*ALDH3B2*) and the other for hydrochlorothiazide (*ALDH1A3*) responsiveness. The human ALDH gene family contains 19 members.^[@b34]^ It is intriguing that 2 other members of this gene family (*ALDH1A2* and *ALDH7*) were found to be associated with the presence of hypertension in African Americans,^[@b38]^ and yet another member (*ALDH2*) associated with BP variation in East Asians.^[@b39]^ ALDHs constitute an important family of enzymes that are able to oxidize a variety of endogenous and exogenous aldehydes that play a role in cell proliferation, differentiation, and responsiveness to environmental stress.^[@b34]^ The links, if any, of ALDHs to regulation of BP and/or antihypertensive drug action remain unknown at present.

Perspectives
------------

Genomic loci influencing responsiveness to antihypertensive drugs are proving difficult to identify, reflecting similar difficulties to identify genetic variants underlying elevated BP per se. We have carried out a genome‐wide analysis of responses of 4 different antihypertensive drugs using very carefully designed experimental conditions. Using GENRES data alone, we could only identify 1 candidate gene locus for hypertension pharmacogenomics: *ACY3* associating with bisoprolol responsiveness. However, use of replication data from 3 other trials provided several additional gene candidates, including those coding for nephrin and members of the aldehyde dehydrogenase family, all of which require additional studies. We did not find evidence for gene loci associating with responsiveness to more than 1 particular class of antihypertensive drugs, suggesting that genetic control of pathways influencing antihypertensive drug responsiveness are drug class--specific. However, since many hypertension genes may show pleiotropic effects on blood pressure pathways, it is possible that the power of our study may simply have been insufficient to detect gene loci interacting with more than 1 class of drugs. In future, even larger carefully controlled prospective clinical studies are needed in which several different antihypertensive drugs are tested. It should be emphasized that although pharmacogenomic prediction of antihypertensive response augmentation on the order of 2 mm Hg may appear minor, in the long term it is translated into a 7% to 10% lower risk of mortality from ischemic heart disease and stroke.^[@b40]^ It is realistic to expect that this level of predictive accuracy in individualized antihypertensive drug therapy could be reached by pharmacogenomic approaches.
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